Search filters

List of works by Jean-Henri Bourhis

Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes

scientific article published on 11 February 2008

Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT

scientific article published on 25 November 2020

Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.

scientific article

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study

scientific article published on 20 June 2011

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & I

scientific article published on 19 December 2014

Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP

scientific article published on 25 December 2019

Expression of CD94 by -differentiated NK cells correlates with the and acquisition of cytotoxic features

scientific article published on 18 July 2017

Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression

scientific article published on March 2002

Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.

scientific article

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation

scientific article published on 8 September 2015

Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial

scientific article published on 28 May 2012

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial

scientific article

Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study

scientific article published on 4 January 2010

The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation

scientific article published on January 2006

Paulina is supported by:

About Paulina

Help